Iridex (IRIX) EBIT Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Iridex | 18.87 Mn | 14.27 Mn | 4.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 1,265.00 |
| Sep 27, 2025 | 967.00 |
| Jun 28, 2025 | 3,784.00 |
| Mar 29, 2025 | 1,660.00 |
| Dec 28, 2024 | 6,056.00 |
| Sep 28, 2024 | 123.00 |
| Jun 29, 2024 | 279.00 |
| Mar 30, 2024 | 66.00 |
| Dec 30, 2023 | 64.00 |
| Sep 30, 2023 | 1,390.00 |
| Jul 1, 2023 | 934.00 |
| Apr 1, 2023 | 2,094.00 |
| Dec 31, 2022 | 4,166.00 |
| Oct 1, 2022 | 1,668.00 |
| Jul 2, 2022 | 1,170.00 |
| Apr 2, 2022 | 71.00 |
| Jan 1, 2022 | 440.00 |
| Oct 2, 2021 | -352.00 |
| Jul 3, 2021 | -517.00 |
| Apr 3, 2021 | -1,667.00 |
| Sep 26, 2020 | -2,243.00 |
| Jun 27, 2020 | -3,650.00 |
| Mar 28, 2020 | -2,206.00 |
| Sep 28, 2019 | -2,337.00 |
| Jun 29, 2019 | -2,745.00 |
| Mar 30, 2019 | -3,443.00 |
| Dec 29, 2018 | -3,061.00 |
| Sep 29, 2018 | -3,401.00 |
| Jun 30, 2018 | -3,744.00 |
| Mar 31, 2018 | -4,807.00 |
| Dec 30, 2017 | -5,425.00 |
| Sep 30, 2017 | -2,092.00 |
| Jul 1, 2017 | -2,326.00 |
| Apr 1, 2017 | -1,488.00 |
| Dec 31, 2016 | -1,244.00 |
| Oct 1, 2016 | -1,858.00 |
| Jul 2, 2016 | -734.00 |
| Apr 2, 2016 | -190.00 |
| Oct 3, 2015 | -4,113.00 |
| Jul 4, 2015 | -1,000.00 |